Andrew Gitkin

Managing Director
Head of West Coast Biotechnology Investment Banking

E-mail  |  Tel: +1 415 616-1628

Andrew Gitkin

Andrew Gitkin is a managing director and head of West Coast biotechnology investment banking at Piper Jaffray.

Gitkin has 20 years of healthcare investment experience, most recently at Moelis & Company, where he was a senior vice president in the life sciences investment banking group. Gitkin was previously with Saddle Point Asset Management where he was a managing member and healthcare portfolio manager. Prior to that, he was a vice president at Tavistock Life Sciences where he was responsible for managing a healthcare-focused investment partnership. Prior to that, he was CEO of Zephyr Sciences, a biotech company engaged in the in-licensing and development of clinical stage compounds. Gitkin was also a senior healthcare analyst in equity research at UBS and SalomonSmithBarney where he was awarded rankings by Institutional Investor and Greenwich Associates. He was also honored by Crain’s Business among the top “Forty Under 40."

Gitkin holds a bachelor’s degree in business administration from the Goizueta School of Business at Emory University.